John Stellini has a general corporate and securities law practice, with an emphasis on the representation of emerging companies, venture capital funds and public companies.
Cooley advised Cellares, the first integrated development and manufacturing organization dedicated to clinical and industrial-scale cell therapy manufacturing, on its $255 million financing.
ACELYRIN Announces Pricing of Upsized Initial Public Offering
May 15, 2023
Cooley advised Acelyrin, INC., a late-stage biopharmaceutical company, in its $621 million initial public offering, the second-largest biotechnology IPO and largest clinical-stage biotechnology IPO ever.
Cooley advised Lively on its $80 million Series C funding round. Partner Gordon Ho led the Cooley team advising Lively, which created the modern health savings account (HSA).
Cooley advised AiFi on its $65 million Series B funding round. Partner Gordon Ho led the Cooley team advising AiFi, which is a flexible artificial intelligence platform that enables retailers to affordably deploy and scale autonomous shopping solutions.
Cooley advised Diamond Age on its $50 million Series A funding round. Partner Gordon Ho led the Cooley team advising Diamond Age, which is a full-stack robotics startup that is automating new home construction to make homeownership more affordable.
